Abstract
Instability in circulation, hypoperfusion, hypoxia, and ischemia in pulmonary thromboembolism (PTE) may occur as a result of failure in pulmonary circulation. All these conditions cause inflammation and oxidative stress. We aimed to investigate inflammatory markers, asymmetric dimethylarginine (ADMA) levels, and the oxidant-antioxidant balance in patients with PTE. This study was conducted as a prospective case-control study. Thirty-eight patients with PTE enrolled to the study. Age- and gender-matched 38 healthy subjects without risk factors for pulmonary embolism were selected as control group. Venous blood samples were obtained from the PTE patients during the initial diagnosis and at the first month of treatment and from the control subjects. Interleukine-6 (IL-6), tumor necrosis factor alpha (TNF-α), total antioxidant status (TAS), total oxidant status (TOS), and ADMA levels were measured for all the samples. The results of patients and healthy subjects were compared. The mean age of the control group was 51.81 ± 15.18 years, and the mean age of the patients was 52.90 ± 18.22 years (p = 0.770). Deep venous thrombosis was present in 68 % of the patients. While we found significant differences between the patient and control groups in terms of IL-6, TAS, TNF-α, ADMA and oxidative stress index (OSI) values (p = 0.001, p = 0.011, p = 0.038, p = 0.028, and p = 0.024, respectively), the TOS value was not different between the groups (p = 0.080). The ADMA, TNF-α, TAS, TOS, and OSI values of the patients during the initial diagnosis and at the first month of treatment were not different (p > 0.05). The results of this study indicate an increased inflammation, endothelial damage, and oxidative stress in PTE. No difference at the first month of therapy suggests ongoing processes. We consider that these markers may be useful in the diagnosis and follow up of PTE.
Similar content being viewed by others
References
Wicki, J., A. Perrier, T.V. Perneger, H. Bounameaux, and A.F. Junod. 2000. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 84: 548–552.
Günay, E., S. Sarinc Ulasli, E. Kacar, B. Halici, E. Unlu, K. Tünay, et al. 2014. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clin Respir J 8(1): 33–40. doi:10.1111/crj.12031.
Girard, P., D. Musset, F. Parent, S. Maitre, C. Phlippoteau, and G. Simonneau. 1999. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 116: 903–908.
Muhl, D., R. Furedi, J. Cristofari, S. Ghosh, L. Bogár, B. Borsiczki, et al. 2006. Evaluation of oxidative stress in the thrombolysis of pulmonary embolism. J Thromb Thrombolysis 22: 221–228.
Sies, H. 1997. Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291–295.
Valdez, L.B., S.L. Arnaiz, J. Bustamante, S. Alvarez, L.E. Costa, and A. Boveris. 2000. Free radical chemistry in biological systems. Biol Res 33: 65–70.
Nijveldt, R.J., T. Teerlink, C. van Guldener, H.A. Prins, A.A. van Lambalgen, C.D. Stehouwer, J.A., et al. 2003. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18: 2542–2550.
Vallance, P., and J. Leiper. 2004. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24: 1023–1030.
Nural, S., E. Günay, B. Halici, S. Celik, and M. Ünlü. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66–74.
Buğdaycı, G., and E. Serin. 2005. Asimetrik Dimetilarginin (ADMA). Düzce Tip Fakultesi Dergisi 2: 36–41.
Erel, O. 2005. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38: 1103–1111.
Erel, O. 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37: 277–285.
Ovechkin, A.V., D. Lominadze, K.C. Sedoris, T.W. Robinson, S.C. Tyagi, and A.M. Roberts. 2007. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113: 1–12.
Re, G., C. Lanzarini, I. Vaona, M. Pazzaglia, G. Palareti, L. Bassein, and C. Guarnieri. 1998. Systemically circulating oxidative species in human deep venous thrombosis. Eur J Emerg Med 5: 9–12.
Dias-Junior, C.A., E.M. Neto-Neves, M.F. Montenegro, and J.E. Tanus-Santos. 2010. Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. Nitric Oxide 23: 284–288.
Sousa-Santos, O., E.M. Neto-Neves, K.C. Ferraz, C.S. Ceron, E. Rizzi, R.F. Gerlach, et al. 2012. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism. Naunyn Schmiedebergs Arch Pharmacol 385: 685–696.
Fox, E.A., and S.R. Kahn. 2005. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94: 362–365.
Marchena Yglesias, P.J., J.A. Nieto Rodríguez, S. Serrano Martínez, O. Belinchón Moya, A. Cortés Carmona, A. Díaz de Tuesta, et al. 2006. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna 23: 105–110.
Jezovnik, M.K., and P. Poredos. 2010. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29: 226–231.
Altuntaş, M., F. Atalay, M. Can, R. Altın, and M. Tor. 2011. Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolism. Mediat Inflamm 2011: 215057.
Bakr, A., O. Pak, A. Taye, F. Hamada, R. Hemeida, W. Janssen, et al. 2013. Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia. Am J Respir Cell Mol Biol 49: 491–500.
Millatt, L.J., G.S. Whitley, D. Li, J.M. Leiper, H.M. Siragy, R.M. Carey, et al. 2003. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 108: 1493–1498.
Pei, Y., P. Ma, X. Wang, W. Zhang, F. Zheng, et al. 2011. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism. Eur J Pharmacol 666: 165–172.
Pullamsetti, S.S., R. Savai, M.B. Schaefer, J. Wilhelm, H.A. Ghofrani, N. Weissmann, et al. 2011. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases. Circulation 123: 1194–1204.
Acknowledgments
This project was supported by a grant from Afyon Kocatepe University Scientific Research Council, Afyonkarahisar, Turkey (Project number 11.TUS.01).
Conflict of interest
The authors declare no potential conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halici, B., Sarinc Ulasli, S., Günay, E. et al. Assessment of Inflammatory Biomarkers and Oxidative Stress in Pulmonary Thromboembolism: Follow-up Results. Inflammation 37, 1186–1190 (2014). https://doi.org/10.1007/s10753-014-9844-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9844-y